MedWatch

Biotech boss overjoyed by new life science fund: "The more the merrier"

Another biotech fund with roots in Scandinavia has been planted, and has been given a warm reception by the chairman of industry association Dansk Biotek. "The Danish biotech sector is in high gear, and it is important to have strong, local funds to lead and participate in financial rounds," says Hans Schambye.

Hans Schambye, chairman of Dansk Biotek and CEO of Galecto Biotech | Photo: Henriette Dan Bonde / PR

Danish industry association Dansk Biotek is ecstatic following the news that another Danish-Swedish venture fund focused on biotech has seen the light of day.

"This is really great news on several levels, and I am very excited. We can only be happy to have another competent player on the market," says Hans Schambye, chairman of industry association Dansk Biotek and CEO of Galecto Biotech, to MedWatch.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs